UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
For the quarterly period ended March 31, 2003
OR
For the transition period from to
Commission file number 1-9810
Owens & Minor, Inc.
(Exact name of Registrant as specified in its charter)
Virginia
54-1701843
(State or other jurisdiction ofincorporation or organization)
(I.R.S. EmployerIdentification No.)
4800 Cox Road, Glen Allen, Virginia
23060
(Address of principal executive offices)
(Zip Code)
Post Office Box 27626, Richmond, Virginia
23261-7626
(Mailing address of principal executive offices)
Registrants telephone number, including area code (804) 747-9794
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
The number of shares of Owens & Minor, Inc.s common stock outstanding as of April 30, 2003, was 33,611,394 shares.
Owens & Minor, Inc. and Subsidiaries
Index
Page
Part I.
Financial Information
Item 1.
Financial Statements
Consolidated Statements of IncomeThree MonthsEnded March 31, 2003 and 2002
3
Consolidated Balance SheetsMarch 31, 2003 and December 31, 2002
4
Consolidated Statements of Cash FlowsThree Months Ended March 31, 2003 and 2002
5
Notes to Consolidated Financial Statements
6
Item 2.
Managements Discussion and Analysis of FinancialCondition and Results of Operations
15
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
17
Item 4.
Controls and Procedures
Part II.
Other Information
Legal Proceedings
18
Item 6.
Exhibits and Reports on Form 8-K
2
Part I. Financial Information
Item 1. Financial Statements
Consolidated Statements of Income
(unaudited)
Three Months EndedMarch 31,
2003
2002
(in thousands, except per share data)
Net sales
$
1,017,969
966,683
Cost of goods sold
909,659
863,652
Gross margin
108,310
103,031
Selling, general and administrative expenses
78,860
75,724
Depreciation and amortization
3,981
Interest expense, net
2,566
2,928
Discount on accounts receivable securitization
204
439
Distributions on mandatorily redeemable preferred securities
1,496
1,774
Total expenses
87,107
84,846
Income before income taxes
21,203
18,185
Income tax provision
8,312
7,365
Net income
12,891
10,820
Net income per common sharebasic
0.38
0.32
Net income per common sharediluted
0.35
0.29
Cash dividends per common share
0.08
0.07
See accompanying notes to consolidated financial statements.
Consolidated Balance Sheets
March 31,2003
December 31,2002
Assets
Current assets
Cash and cash equivalents
3,390
3,361
Accounts and notes receivable, netof allowances of $7,529 and $6,849
340,590
354,856
Merchandise inventories
370,782
351,835
Other current assets
19,203
19,701
Total current assets
733,965
729,753
Property and equipment, net of accumulateddepreciation of $72,181 and $70,528
20,569
21,808
Goodwill
198,139
Other assets, net
57,904
59,777
Total assets
1,010,577
1,009,477
Liabilities and shareholders equity
Current liabilities
Accounts payable
306,340
259,597
Accrued payroll and related liabilities
6,756
12,985
Other accrued liabilities
69,158
72,148
Total current liabilities
382,254
344,730
Long-term debt
224,076
240,185
Other liabilities
28,374
27,975
Total liabilities
634,704
612,890
Company-obligated mandatorily redeemable preferred securities of subsidiary trust, holding solely convertible debentures of Owens & Minor, Inc.
104,378
125,150
Shareholders equity
Preferred stock, par value $100 per share; authorized10,000 shares Series A; Participating Cumulative Preferred Stock; none issued
Common stock, par value $2 per share; authorized200,000 shares; issued and outstanding33,554 shares and 34,113 shares
67,108
68,226
Paid-in capital
21,088
30,134
Retained earnings
189,765
179,554
Accumulated other comprehensive loss
(6,466
)
(6,477
Total shareholders equity
271,495
271,437
Total liabilities and shareholders equity
Consolidated Statements of Cash Flows
Three Months Ended
March 31,
(in thousands)
Operating activities
Adjustments to reconcile net income to cash provided by (used for) operating activities:
Provision for LIFO reserve
2,700
3,180
Provision for losses on accounts and notes receivable
759
708
Changes in operating assets and liabilities:
Accounts and notes receivable, excluding sales of receivables
13,507
(30,688
Net decrease in receivables sold
(30,000
(21,647
40,822
74,743
(6,594
Net change in other current assets and current liabilities
(8,721
(4,180
394
418
Other, net
1,481
1,425
Cash provided by (used for) operating activities
80,088
(10,108
Investing activities
Additions to property and equipment
(690
(1,332
Additions to computer software
(2,080
(837
(15
Cash used for investing activities
(2,766
(2,184
Financing activities
Payments to repurchase mandatorily redeemable preferred securities
(20,412
Payments to repurchase common stock
(10,884
Net payments on revolving credit facility
(16,000
Cash dividends paid
(2,680
(2,382
Proceeds from exercise of stock options
683
1,409
Increase (decrease) in drafts payable
(28,000
13,000
Cash provided by (used for) financing activities
(77,293
12,027
Net increase (decrease) in cash and cash equivalents
29
(265
Cash and cash equivalents at beginning of period
953
Cash and cash equivalents at end of period
688
In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (which are comprised only of normal recurring accruals and the use of estimates) necessary to present fairly the consolidated financial position of Owens & Minor, Inc. and its wholly-owned subsidiaries (O&M or the company) as of March 31, 2003 and the consolidated results of operations and cash flows for the three month periods ended March 31, 2003 and 2002.
The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.
Certain prior period amounts have been reclassified in order to conform to the current period presentation.
The company uses the intrinsic value method as defined by Accounting Principles Board Opinion No. 25 to account for stock-based compensation. This method requires compensation expense to be recognized for the excess of the quoted market price of the stock at the grant date or the measurement date over the amount an employee must pay to acquire the stock. The following table presents the effect on net income and earnings per share had the company used the fair value method, as defined in Statement of Financial Accounting Standards No. (SFAS) 123, Accounting for Stock-Based Compensation, to account for stock-based compensation:
Add: Stock-based employee compensation expense included in reported net income, net of tax
180
145
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of tax
(408
(349
Pro forma net income
12,663
10,616
Per common sharebasic:
Net income, as reported
0.31
Per common sharediluted:
0.34
In 1999, the company acquired certain net assets of Medix, Inc. (Medix), a distributor of medical and surgical supplies. The acquisition was accounted for by the purchase method. In connection with the acquisition, management adopted a plan for integration of the businesses that included closure of some Medix facilities and consolidation of certain administrative functions. An accrual was established to provide for certain costs of this plan. The following table sets forth the activity in the accrual since December 31, 2002:
Balance at
December 31,
Charges
Losses under lease commitments
115
30
85
Other
40
Total
155
125
The integration of the Medix business was completed in 2001. However, the company continues to make payments under lease commitments and other obligations.
As a result of the cancellation of a significant customer contract in 1998, the company recorded a restructuring charge to downsize operations. In the first quarter of 2003, the company reduced the accrual by $53 thousand due to the reutilization of space that had been vacated under the plan. The following table sets forth the activity in the restructuring reserve since December 31, 2002:
Adjustment
595
34
(53
508
Asset write-offs
317
912
351
The companys comprehensive income for the three months ended March 31, 2003 and 2002 is shown in the table below:
Other comprehensive incomechange in unrealized gain on investment, net of tax
11
(123
Comprehensive income
12,902
10,697
7
The following sets forth the computation of basic and diluted net income per common share:
Numerator:
Numerator for basic net income per common sharenet income
Distributions on convertible mandatorily redeemable preferred securities, net of income taxes
913
1,064
Numerator for diluted net income per common sharenet income attributable to common stock after assumed conversions
13,804
11,884
Denominator:
Denominator for basic net income per common shareweighted average shares
33,534
33,708
Effect of dilutive securities:
Conversion of mandatorily redeemable preferred securities
5,575
6,400
Stock options and restricted stock
419
644
Denominator for diluted net income per common shareadjusted weighted average shares and assumed conversions
39,528
40,752
On January 1, 2003, the company adopted the provisions of SFAS 143, Accounting for Asset Retirement Obligations. The provisions of SFAS 143 address financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and the associated asset retirement costs. Adoption of this standard did not have a material effect on the companys financial condition or results of operations.
On January 1, 2003, the company adopted the provisions of SFAS 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. The most significant provisions of SFAS 145 address the termination of extraordinary item treatment for gains and losses on early retirement of debt. As a result, effective January 1, 2003, the company presents gains and losses on early retirement of debt within income from continuing operations. Adoption of this standard did not affect the companys financial condition or results of operations.
On January 1, 2003, the company adopted the provisions of SFAS 146, Accounting for Costs Associated with Exit or Disposal Activities. The provisions of SFAS 146 modify the accounting for the costs of exit and disposal activities by requiring that liabilities for those activities be recognized when the liability is incurred. Previous accounting literature permitted recognition of some exit and disposal liabilities at the date of commitment to an exit plan. The provisions of this statement are effective for exit or disposal activities initiated after December 31, 2002.
In November 2002, the FASB issued Interpretation No. 45,Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of FASB Interpretation No. 34 . This Interpretation elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under guarantees issued. The Interpretation also clarifies that a guarantor is required to recognize, at inception of a guarantee, a liability for the fair value of the obligation undertaken. The initial recognition and measurement
8
provisions of the Interpretation were applicable to guarantees issued or modified after December 31, 2002, and did not have a material effect on the companys financial condition or results of operations.
In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, an interpretation of ARB No. 51. This Interpretation addresses the consolidation by business enterprises of variable interest entities as defined in the Interpretation. The Interpretation applies immediately to variable interests in variable interest entities created after January 31, 2003, and to variable interests in variable interest entities obtained after January 31, 2003. For variable interests in a variable interest entity created before February 1, 2003, the Interpretation is applicable as of July 1, 2003. The application of this Interpretation did not have a material effect on the companys financial condition or results of operations.
9
The following tables present condensed consolidating financial information for: Owens & Minor, Inc.; on a combined basis, the guarantors of Owens & Minor, Inc.s Notes; and the non-guarantor subsidiaries of the Notes. Separate financial statements of the guarantor subsidiaries are not presented because the guarantors are jointly, severally and unconditionally liable under the guarantees and the company believes the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries.
For the three months ended
March 31, 2003
Guarantor Subsidiaries
Non-guarantor
Subsidiaries
Consolidated
Statements of Operations
78,302
558
(1,105
6,554
(2,883
199
88,842
(630
1,105
19,468
630
434
7,631
247
671
11,837
383
March 31, 2002
75,323
401
(1,541
7,863
(3,394
436
87,170
(783
1,541
15,861
783
655
6,377
333
886
9,484
450
10
Condensed Consolidating Financial Information
Owens &
Minor, Inc.
Guarantor
Eliminations
Balance Sheets
1,321
2,068
1
Accounts and notes receivable, net
2,673
337,917
Intercompany advances, net
145,275
157,239
(302,514
19,198
146,601
551,960
35,404
Property and equipment, net
Intercompany investments
387,498
22,773
108,461
(518,732
19,933
37,971
554,032
831,412
143,865
2,553
65,610
995
378,706
Intercompany long-term debt
188,890
(297,351
335,090
595,970
Common stock
5,583
(5,583
199,797
16,001
(215,798
130,671
42,186
16,908
Accumulated other comprehensive income (loss)
75
(6,541
218,942
235,442
38,492
(221,381
December 31, 2002
1,244
2,116
3,592
351,264
196,804
119,253
(316,057
21
19,680
198,069
496,476
35,208
129,233
(539,504
20,835
38,942
606,402
778,138
164,441
5,880
65,086
1,182
337,668
(318,123
375,298
554,533
132,680
30,349
16,525
64
231,104
223,605
38,109
12
Statements of Cash Flows
672
11,836
206
553
Accounts and notes receivable
713
12,794
(3,311
(5,223
(187
480
1,001
(2,159
68,704
13,543
Change in intercompany advances
51,529
(37,986
(13,543
Decrease in drafts payable
2,236
(65,986
77
(48
13
315
393
(9,982
(20,706
(4,586
427
(21
885
537
(2,815
42,588
(49,881
3,903
(53,784
49,881
Increase in drafts payable
2,930
(40,784
(380
507
445
622
65
14
Item 2.Managements Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis describes material changes in the financial condition of Owens & Minor, Inc. and its wholly-owned subsidiaries (O&M or the company) since December 31, 2002. Trends of a material nature are discussed to the extent known and considered relevant. This discussion should be read in conjunction with the consolidated financial statements, related notes thereto and managements discussion and analysis of financial condition and results of operations included in the companys 2002 Annual Report on Form 10-K for the year ended December 31, 2002.
Results of Operations
First quarter of 2003 compared with first quarter of 2002
Overview. In the first quarter of 2003, the company earned net income of $12.9 million, or $0.35 per diluted common share, compared with $10.8 million, or $0.29 per diluted common share in the first quarter of 2002. The increase in net income resulted from increased sales, reduced financing costs, improved productivity in field operations and a lower effective tax rate. The company also focused on the implementation of new strategic initiatives, launched in late 2002, by hiring new staff and marketing new services to customers. The company expects to continue to invest in these initiatives, which include the OMSolutionsSM and third-party logistics services, and Owens & Minor University, the companys new in-house training program, throughout the year.
Net sales. Net sales increased 5% to $1.02 billion in the first quarter of 2003 from $966.7 million in the first quarter of 2002. This increase in sales resulted primarily from penetration of existing accounts.
Gross margin. Gross margin for the first quarter of 2003 was 10.6% of net sales, down from 10.7% of sales in the first quarter of 2002, but consistent with the gross margin of 10.6% reported for the full year of 2002.
Selling, general and administrative expenses. Selling, general and administrative (SG&A) expenses for the first quarter of 2003 were 7.7% of net sales, improved from 7.8% of net sales in the first quarter of 2002, as a result of productivity savings, partially offset by investments in strategic initiatives. The company expects to continue investing in these initiatives throughout 2003.
Financing costs. Financing costs, which include interest expense, net of finance charge collections; discount on accounts receivable securitization; and distributions on mandatorily redeemable preferred securities, totaled $4.3 million for the first quarter of 2003, compared with $5.1 million for the first quarter of 2002. Excluding collections of customer finance charges, financing costs for the first quarter were $5.4 million, a decrease of $0.5 million from the first quarter of 2002. The decrease in financing costs from the first quarter of 2002 resulted from an overall decrease in the companys outstanding financing, including the repurchase of $27.6 million in mandatorily redeemable preferred securities and a $40 million reduction in sales of accounts receivable under the companys off balance sheet receivables financing facility (Receivables Financing Facility) since the first quarter of 2002.
The company expects to continue to manage its financing costs by managing working capital levels. Future financing costs will be affected primarily by changes in short-term interest rates, as well as working capital requirements.
Income taxes. The income tax provision was $8.3 million in the first quarter of 2003 compared with $7.4 million in the same period of 2002. The effective tax rate was 39.2% for the first quarter of 2003, compared to 39.6% for the full year of 2002. This rate decrease results primarily from lower nondeductible expenses.
Financial Condition, Liquidity and Capital Resources
Liquidity. From December 31, 2002 to March 31, 2003, the company reduced its debt from $240.2 million to $224.1 million. During this period, the company also spent $20.4 million to repurchase 415,449 shares of its $2.6875 Term Convertible Securities, Series A (Trust Preferred Securities) and $10.9 million to repurchase 661,500 shares of common stock under a $50 million repurchase plan initiated in late 2002. These repurchases, as well as the reduction of debt, were primarily funded by operating cash flows. As of March 31, 2003, the company had repurchased $27.6 million of Trust Preferred Securities and $10.9 million of common stock, for a total of $38.5 million of the $50 million authorized under the plan, which expires December 31, 2003.
In the first three months of 2003, $80.1 million of cash was provided by operating activities, compared with $10.1 million used for operating activities in the first quarter of 2002. Cash flows in the first quarter of 2003 were positively affected by the timing of payments for inventory purchases as well as strong asset management. In the first quarter of 2002, the company reduced its sales of accounts receivable under the Receivables Financing Facility, resulting in a $30 million decrease in operating cash flow. The company uses the facility as a source of short-term financing, selling receivables as needed to provide cash for operations.
The company expects that its available financing will be sufficient to fund its working capital needs and long-term strategic growth, although this cannot be assured. At March 31, 2003, the company had $134.1 million of unused credit under its revolving credit facility and $225.0 million of unused financing under its Receivables Financing Facility.
Capital Expenditures. Capital expenditures were $2.8 million in the first quarter of 2003, compared to $2.2 million in the first quarter of 2002. Expenditures for computer hardware and software increased to $2.3 million from $1.4 million in the first quarter of 2002, as the company focused on upgrading its information systems. The company expects capital expenditures for 2003 to continue to run at a higher rate than in 2002 as it enhances its information systems to support its strategic initiatives.
Risks
The company is subject to risks associated with changes in the medical industry, including continued efforts to control costs, which place pressure on operating margin, changes in the way medical and surgical services are delivered and changes in manufacturer preferences between the sale of product directly to hospital customers and the use of wholesale distribution. The loss of one of the companys larger customers could have a significant effect on its business.
Forward-looking Statements
Certain statements in this discussion constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although O&M believes its expectations with respect to the forward-looking statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, all forward-looking statements involve risks and uncertainties and, as a result, actual results could differ materially from those projected, anticipated or implied by these statements. Such forward-looking statements involve known and unknown risks,
16
including, but not limited to: general economic and business conditions; the ability of the company to implement its strategic initiatives; dependence on sales to certain customers; dependence on suppliers; changes in manufacturer preferences between direct sales and wholesale distribution; competition; changing trends in customer profiles; the ability of the company to meet customer demand for additional value added services; the ability to convert customers to CostTrackSM; the availability of supplier incentives; the ability to capitalize on buying opportunities; the ability of business partners to perform their contractual responsibilities; the ability to manage operating expenses; the ability of the company to manage financing costs and interest rate risk; the risk that a decline in business volume or profitability could result in an impairment of goodwill; the ability to timely or adequately respond to technological advances in the medical supply industry; the ability to successfully identify, manage or integrate possible future acquisitions; outcome of outstanding litigation; and changes in government regulations. As a result of these and other factors, no assurance can be given as to the companys future results. The company is under no obligation to update or revise any forward-looking statements, whether as a result of new information, future results, or otherwise.
Item 3.Quantitative and Qualitative Disclosures About Market Risk
The company believes there has been no material change in its exposure to market risk from that discussed in Item 7A in the companys Annual Report on Form 10-K for the year ended December 31, 2002.
Item 4.Controls and Procedures
Within the 90 days prior to the filing date of this report, under the supervision and with the participation of the Companys management (including its Chief Executive Officer and Chief Financial Officer), the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures pursuant to Rule 13a-14 under the Securities Exchange Act of 1934. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Companys disclosure controls and procedures are effective in timely alerting them to material information relating to the Company required to be included in the Companys periodic SEC filings. Since the date of the evaluation, there have been no significant changes in the Companys internal controls or factors that could significantly affect them.
Part II.Other Information
Item 1.Legal Proceedings
Certain legal proceedings pending against the company are described in the companys Annual Report on Form 10-K for the year ended December 31, 2002. Through March 31, 2003, there have been no material developments in any legal proceedings reported in such Annual Report.
Item 6.Exhibits and Reports on Form 8-K.
(a)
Exhibits
99.1
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.2
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(b)
Reports on Form 8-K
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC.
(Registrant)
Date May 13, 2003
/S/ G. GILMER MINOR, III
G. Gilmer Minor, III
Chairman and Chief Executive Officer
/S/ JEFFREYKACZKA
Jeffrey Kaczka
Senior Vice President
Chief Financial Officer
/S/ OLWEN B. CAPE
Olwen B. Cape
Vice President & Controller
Chief Accounting Officer
I, G. Gilmer Minor, III, certify that:
Date: May 13, 2003
Chief Executive Officer
I, Jeffrey Kaczka, certify that:
Exhibits Filed with SEC
Exhibit #